A. John Camm

3.5k total citations · 2 hit papers
36 papers, 2.5k citations indexed

About

A. John Camm is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, A. John Camm has authored 36 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Cardiology and Cardiovascular Medicine, 4 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in A. John Camm's work include Cardiac Arrhythmias and Treatments (17 papers), Atrial Fibrillation Management and Outcomes (17 papers) and Cardiac electrophysiology and arrhythmias (17 papers). A. John Camm is often cited by papers focused on Cardiac Arrhythmias and Treatments (17 papers), Atrial Fibrillation Management and Outcomes (17 papers) and Cardiac electrophysiology and arrhythmias (17 papers). A. John Camm collaborates with scholars based in United Kingdom, Netherlands and Italy. A. John Camm's co-authors include Harry J.G.M. Crijns, Alessandro Capucci, Robby Nieuwlaat, Günter Breithardt, S. Bertil Olsson, Martin H. Prins, Samuel Lévy, Marek Malík, D. Wyn Davies and Albert L. Waldo and has published in prestigious journals such as The Lancet, Circulation and Journal of the American College of Cardiology.

In The Last Decade

A. John Camm

36 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Atrial fibrillation management: a prospective survey in ESC Member Countries

2005 586 citations Robby Nieuwlaat, Alessandro Capucci et al. European Heart Journal profile →
Pathophysiology and Prevention of Atrial Fibrillation

2001 541 citations A. John Camm et al. profile →

Peers

Countries citing papers authored by A. John Camm

Since Specialization

Citations

This map shows the geographic impact of A. John Camm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. John Camm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. John Camm more than expected).

Fields of papers citing papers by A. John Camm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. John Camm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. John Camm. The network helps show where A. John Camm may publish in the future.

Co-authorship network of co-authors of A. John Camm

This figure shows the co-authorship network connecting the top 25 collaborators of A. John Camm. A scholar is included among the top collaborators of A. John Camm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. John Camm. A. John Camm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Safety and efficacy of amiodarone and dronedarone for early rhythm control in EAST-AFNET 4 2025 ·Clinical Research in Cardiology ·Laura Rottner, Marc D. Lemoine, Lars Eckardt, Katrin Borof, A. John Camm, Andreas Goette, Günter Breithardt, Andreas Metzner, Ulrich Schotten, Antonia Zapf, Hein Heidbüchel, Stephan Willems, Harry J. Crijns, Renate B. Schnabel, Larissa Fabritz, Christina Magnussen, Andreas Rillig, Paulus Kirchhof	1
2	Effect of Systemic Hypertension With Versus Without Left Ventricular Hypertrophy on the Progression of Atrial Fibrillation (from the Euro Heart Survey) 2018 ·The American Journal of Cardiology ·Ömer Erküner, Elton Dudink, Robby Nieuwlaat, Michiel Rienstra, Isabelle C. Van Gelder, A. John Camm, Alessandro Capucci, Günter Breithardt, (unknown), Gregory Y.H. Lip, Harry J.G.M. Crijns, (unknown)	12
3	The unravelling of primary myocardial impairment in Marfan syndrome by modern echocardiography 2009 ·Heart ·Anatoli Kiotsekoglou, George R. Sutherland, James Moggridge, D. K. Nassiri, A. John Camm, Anne H. Child	21
4	Assessment of regional left ventricular systolic function using strain and strain rate echocardiography in adult patients with Marfan syndrome 2008 ·European Heart Journal ·Anatoli Kiotsekoglou, (unknown), Bart Bijnens, (unknown), James Moggridge, (unknown), D. K. Nassiri, A. John Camm, A Child	2
5	Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation? 2008 ·European Heart Journal ·Robby Nieuwlaat, Trang Dinh, Sandra Olsson, A. John Camm, Alessandro Capucci, R. G. Tieleman, Gregory Y.H. Lip, Harry J.G.M. Crijns, (unknown)	74
6	Combined Metabolomic and Proteomic Analysis of Human Atrial Fibrillation 2008 ·Journal of the American College of Cardiology ·Manuel Mayr, Shamil Yusuf, Graeme Weir, Yuen-Li Chung, Ursula Mayr, Xiaoke Yin, Christophe Ladroue, Basetti Madhu, Neil Roberts, (unknown), Salim Fredericks, Marion Stubbs, John R. Griffiths, Marjan Jahangiri, Qingbo Xu, A. John Camm	179
7	Autonomic trigger patterns and anti-arrhythmic treatment of paroxysmal atrial fibrillation: data from the Euro Heart Survey 2008 ·European Heart Journal ·Cees B. de Vos, (unknown), Harry J.G.M. Crijns, A. John Camm, (unknown), (unknown), Alessandro Capucci, Günter Breithardt, Panagiotis Vardas, Ron Pisters, R. G. Tieleman	75
8	Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation 2007 ·American Heart Journal ·Robby Nieuwlaat, S. Bertil Olsson, Gregory Y.H. Lip, A. John Camm, Günter Breithardt, Alessandro Capucci, Joan G. Meeder, Martin H. Prins, Samuel Lévy, Harry J.G.M. Crijns	167
9	Atrial fibrillation management: a prospective survey in ESC Member Countries breakdown → 2005 ·European Heart Journal ·Robby Nieuwlaat, Alessandro Capucci, A. John Camm, S. Bertil Olsson, Dietrich Andresen, D. Wyn Davies, Stuart M. Cobbe, Günter Breithardt, Jean‐Yves Le Heuzey, Martin H. Prins, Samuel Lévy, Harry J.G.M. Crijns	586
10	Effects of ventricular rate and regularity on the velocity and magnitude of left atrial appendage flow in atrial fibrillation 2005 ·Heart ·Owen Obel, Lisa Luddington, (unknown), Kudret Aytemir, (unknown), Marek Malík, A. John Camm	11
11	Atrial fibrillation: Is there a role for low-molecular-weight heparin? 2001 ·Clinical Cardiology ·A. John Camm	17
12	Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial 2000 ·The Lancet ·Lars Køber, Poul Erik Bloch Thomsen, Mogens Møller, Christian Torp-Pedersen, Jan E. Carlsen, Erik Sandøe, Kenneth Egstrup, E Agner, Jørgen Videbæk, Bradley Marchant, A. John Camm	235
13	Acute Treatment of Atrial Fibrillation: Why and When to Maintain Sinus Rhythm 1998 ·The American Journal of Cardiology ·Johan Waktare, A. John Camm	53
14	Effects of procainamide on the signal-averaged electrocardiogram in relation to the results of programmed ventricular stimulation in patients with sustained monomorphic ventricular tachycardia 1993 ·Journal of the American College of Cardiology ·Piotr Kułakowski, Yaver Bashir, S. Heald, (unknown), Mark Anderson, Sheila Gibson, Marek Malík, A. John Camm	8
15	Electrophysiologic studies in atrial flutter 1992 ·Clinical Cardiology ·Francisco G. Cosío, (unknown), Antonio Goicolea, Fernando Arribas, A. John Camm	49
16	Heart rate variability: An important new risk factor in patients following myocardial infarction 1991 ·Clinical Cardiology ·A. John Camm, D J Ewing	39
17	Critical noise level reduction for correct identification of late potentials: An illustrative case report 1991 ·Clinical Cardiology ·Piotr Kułakowski, Francis Murgatroyd, A. John Camm	1
18	The Monophasic Action Potential in Clinical Cardiology 1991 ·Clinical Cardiology ·(unknown), Warren M. Jackman, Benjamin J. Scherlag, (unknown), A. John Camm	7
19	Circadian rhythm of heart rate variability after acute myocardial infarction and its influence on the prognostic value of heart rate variability 1990 ·The American Journal of Cardiology ·Marek Malík, Thomas Farrell, A. John Camm	145
20	Calcium antagonist withdrawal syndrome 1983 ·BMJ ·(unknown), A. John Camm	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact